Everything listed here is Research Use Only (RUO). Not for human or animal consumption.
Healing, Recovery & Immune · Boston, MA
LL-37 is documented by ReVia for Boston's research community, including the immunology and microbiology groups that populate the Cambridge and greater-Boston biotech hub. This human cathelicidin antimicrobial peptide is studied for broad-spectrum pathogen defense, immune modulation, and wound-healing mechanisms in research settings, and is supplied for laboratory use only. Each LL-37 vial is backed by third-party COA testing so investigators can validate purity before experiments.
The sole human cathelicidin-derived antimicrobial peptide. Studies have investigated its broad-spectrum antimicrobial activity, immunomodulatory functions, and role in innate immune defense.
LL-37 is a heavily studied cathelicidin antimicrobial peptide within the country's leading biotech and life-science hub, where investigators probe its in-vitro membrane permeabilization and innate-immune roles. Boston laboratories, joined by teams in Cambridge, Quincy, and Newton, characterize its peptide chemistry and structure-function relationships under controlled conditions, keeping the compound firmly within preclinical host-defense research across the region's institutional density.
LL-37 is worked with by researchers throughout the Boston metro — including Cambridge, Quincy, Newton, Somerville — and across East Coast. The country's leading biotech and life-science hub. Every ReVia-branded lot carries its own certificate of analysis, and the compound is intended strictly for research use.
Where do researchers in Boston area obtain LL-37?
LL-37 as a research-use-only product is supplied through i2b Health, ReVia's research partner, to researchers in Boston and surrounding communities such as Cambridge, Quincy, and Newton with tracked delivery to qualified labs.
Is there a COA available for LL-37?
Yes. LL-37 is independently tested by a third-party laboratory, and the COA documenting identity and purity is available to researchers.
What is LL-37 researched for?
LL-37 is studied as a cathelicidin antimicrobial peptide for broad-spectrum pathogen defense, immune modulation, and wound-healing pathways in laboratory models. It is intended for research use only.
For research use only. Not for human or veterinary use. The information on this page is provided for educational and research purposes and does not constitute medical advice.